FDA seeks input into 'opaque' priority voucher scheme FDA seeks public input on controversial priority voucher scheme amid concerns about its transparency and legality.

#FDA seeks public input on controversial #CNPV priority voucher scheme amid concerns about its transparency and legality.

Some MAHA Supporters Say CNPV Could Lower FDA Standards - National Center for Health Research October 23, 2025: Inside Health Policy quotes a MAHA meeting that criticized industry influence over FDA, the impact of user fees, the inappropriate reliance on surrogate endpoints for cancer screenin...

#FDA #DrugSafety #PublicHealth #ClinicalTrials #HealthPolicy #CNPV

www.center4research.org/inside-healt...

Screenshot of the list/descriptions of the 9 drugs in question, taken from the linked press release

"[US] FDA Awards First-Ever National Priority Vouchers to Nine Sponsors" under the Commissioner’s National Priority Voucher ( #CNPV) pilot program
www.fda.gov/news-events/...

FDA unveils fast-track review path for 'national priorities' FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national priority for the US

#USA #pharmaceuticals #FDA #fasttrackreviewpath #CommissionersNationalPriorityVoucherprogramme #CNPVprogramme #CNPV #unmetpublichealthneeds #domesticdrugmanufacturing #medicaldecisionmaking #FDApathways #priorityreviewvouchers #PRVs #orphandrugs #biotechs
pharmaphorum.com/news/fda-unv...